Magnitude of Slowing Gastric Emptying by Glucagon-like Peptide-1 Receptor Agonists Determines the Amelioration of Postprandial Glucose Excursion in Japanese Patients with Type 2 Diabetes

Overview

Journal J Diabetes Investig

Specialty Endocrinology

Date 2019 Jul 14

PMID 31301103

Citations 8

Authors

Yumi Suganuma

Tatsunori Shimizu

Takehiro Sato

Tsukasa Morii

Hiroki Fujita

Mariko Harada Sassa

Yuichiro Yamada

Affiliations

Soon will be listed here.

Abstract

Aims/introduction: Pharmacological levels of glucagon-like peptide-1 (GLP-1) can decelerate gastric emptying (GE) and reduce postprandial glucose levels. Most previous studies have used liquid meals to evaluate GE. We evaluated the effects of GLP-1 receptor agonists (GLP-1 RAs) on GE and postprandial glucose excursion in Japanese type 2 diabetes mellitus patients using a combination of solid and liquid meals.

Materials And Methods: In this single-center, prospective, open-label study, nine healthy individuals and 17 patients with type 2 diabetes mellitus consumed a 460-kcal combination of a solid and liquid meal labeled with C-acetic acid. GE was measured from t = 0 to 150 min in a continuous C breath test. Eight participants with type 2 diabetes mellitus were administered GLP-1 RAs, and we examined the relationship between GE and blood glucose excursion.

Results: There were no differences in the average GE coefficient (GEC) and lag time between the healthy and type 2 diabetes mellitus groups. However, the type 2 diabetes mellitus group showed larger GEC variations (P < 0.05). The coefficient of variation of R-R intervals was a significant predictor of GEC in type 2 diabetes mellitus patients (P < 0.01). The short-acting GLP-1 RA reduced the GEC at 1 month (P = 0.012), whereas the long-acting GLP-1 RA did not significantly change the GEC after treatment. A positive relationship was observed between postprandial glucose excursion from T to T and the GEC (r = 0.75; P < 0.01).

Conclusions: The reduction in GE rate by the administration of GLP-1 RAs can predict the improvement in postprandial glucose excursion in type 2 diabetes mellitus patients.

Citing Articles

From diabetes to diverse domains: the multifaceted roles of GLP-1 receptor agonists.

Dave B, Chorawala M, Shah I, Shah N, Bhagat S, Prajapati B Mol Biol Rep. 2024; 51(1):835.

PMID: 39042283 DOI: 10.1007/s11033-024-09793-y.

Gastroparesis with bezoar formation in patients treated with glucagon-like peptide-1 receptor agonists: potential relevance for bariatric and other gastric surgery.

Preda V, Khoo S, Preda T, Lord R BJS Open. 2023; 7(1).

PMID: 36723995 PMC: 9891341. DOI: 10.1093/bjsopen/zrac169.

Semaglutide is effective in type 2 diabetes and obesity with schizophrenia.

Noda K, Kato T, Nomura N, Sakai M, Kubota S, Hirose T Diabetol Int. 2022; 13(4):693-697.

PMID: 36117924 PMC: 9477985. DOI: 10.1007/s13340-022-00590-1.

A Pilot Study to Assess Glucose, Insulin, and Incretin Responses Following Novel High Resistant Starch Rice Ingestion in Healthy Men.

Takahashi K, Fujita H, Fujita N, Takahashi Y, Kato S, Shimizu T Diabetes Ther. 2022; 13(7):1383-1393.

PMID: 35708892 PMC: 9240163. DOI: 10.1007/s13300-022-01283-3.

Effects of efpeglenatide versus liraglutide on gastric emptying, glucose metabolism and beta-cell function in people with type 2 diabetes: an exploratory, randomized phase Ib study.

Hompesch M, Kang J, Han O, Trautmann M, Sorli C, Ogbaa I BMJ Open Diabetes Res Care. 2021; 9(1).

PMID: 34172436 PMC: 8237726. DOI: 10.1136/bmjdrc-2021-002208.

References

Horowitz M, Maddox A, Wishart J, Harding P, Chatterton B, Shearman D . Relationships between oesophageal transit and solid and liquid gastric emptying in diabetes mellitus. Eur J Nucl Med. 1991; 18(4):229-34. DOI: 10.1007/BF00186645. View

Yamada Y, Fukuda K, Fujimoto S, Hosokawa M, Tsukiyama K, Nagashima K . SUIT, secretory units of islets in transplantation: An index for therapeutic management of islet transplanted patients and its application to type 2 diabetes. Diabetes Res Clin Pract. 2006; 74(3):222-6. DOI: 10.1016/j.diabres.2006.03.030. View

NUSYNOWITZ M, Benedetto A . The lag phase of gastric emptying: clinical, mathematical and in vitro studies. J Nucl Med. 1994; 35(6):1023-7. View

Enc F, Imeryuz N, Akin L, Turoglu T, Dede F, Haklar G . Inhibition of gastric emptying by acarbose is correlated with GLP-1 response and accompanied by CCK release. Am J Physiol Gastrointest Liver Physiol. 2001; 281(3):G752-63. DOI: 10.1152/ajpgi.2001.281.3.G752. View

Meier J . GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus. Nat Rev Endocrinol. 2012; 8(12):728-42. DOI: 10.1038/nrendo.2012.140. View

Ghoos Y, Maes B, Geypens B, Mys G, Hiele M, Rutgeerts P . Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test. Gastroenterology. 1993; 104(6):1640-7. DOI: 10.1016/0016-5085(93)90640-x. View

Nauck M, Kemmeries G, Holst J, Meier J . Rapid tachyphylaxis of the glucagon-like peptide 1-induced deceleration of gastric emptying in humans. Diabetes. 2011; 60(5):1561-5. PMC: 3292331. DOI: 10.2337/db10-0474. View

Abell T, Camilleri M, Donohoe K, Hasler W, Lin H, Maurer A . Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. J Nucl Med Technol. 2008; 36(1):44-54. DOI: 10.2967/jnmt.107.048116. View

Jones K, Russo A, Stevens J, Wishart J, Berry M, Horowitz M . Predictors of delayed gastric emptying in diabetes. Diabetes Care. 2001; 24(7):1264-9. DOI: 10.2337/diacare.24.7.1264. View

10.

Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, Sekikawa A . Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care. 1999; 22(6):920-4. DOI: 10.2337/diacare.22.6.920. View

11.

Wheeler T, Watkins P . Cardiac denervation in diabetes. Br Med J. 1973; 4(5892):584-6. PMC: 1587717. DOI: 10.1136/bmj.4.5892.584. View

12.

Stevens J, Jones K, Rayner C, Horowitz M . Pathophysiology and pharmacotherapy of gastroparesis: current and future perspectives. Expert Opin Pharmacother. 2013; 14(9):1171-86. DOI: 10.1517/14656566.2013.795948. View

13.

Linnebjerg H, Park S, Kothare P, Trautmann M, Mace K, Fineman M . Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes. Regul Pept. 2008; 151(1-3):123-9. DOI: 10.1016/j.regpep.2008.07.003. View

14.

Kusunoki H, Haruma K, Hata J, Kamada T, Ishii M, Yamashita N . Efficacy of mosapride citrate in proximal gastric accommodation and gastrointestinal motility in healthy volunteers: a double-blind placebo-controlled ultrasonographic study. J Gastroenterol. 2010; 45(12):1228-34. DOI: 10.1007/s00535-010-0292-7. View

15.

Jones K, Horowitz M, Wishart M, Maddox A, Harding P, Chatterton B . Relationships between gastric emptying, intragastric meal distribution and blood glucose concentrations in diabetes mellitus. J Nucl Med. 1995; 36(12):2220-8. View

16.

Salehi M, DAlessio D . Effects of glucagon like peptide-1 to mediate glycemic effects of weight loss surgery. Rev Endocr Metab Disord. 2014; 15(3):171-9. PMC: 4119589. DOI: 10.1007/s11154-014-9291-y. View

17.

Jones K, Horowitz M, Carney B, Wishart J, Guha S, Green L . Gastric emptying in early noninsulin-dependent diabetes mellitus. J Nucl Med. 1996; 37(10):1643-8. View

18.

Usui R, Yabe D, Kuwata H, Murotani K, Kurose T, Seino Y . Retrospective analysis of safety and efficacy of liraglutide monotherapy and sulfonylurea-combination therapy in Japanese type 2 diabetes: Association of remaining β-cell function and achievement of HbA1c target one year after initiation. J Diabetes Complications. 2015; 29(8):1203-10. DOI: 10.1016/j.jdiacomp.2015.07.020. View

19.

Lorenz M, Pfeiffer C, Steinstrasser A, Becker R, Rutten H, Ruus P . Effects of lixisenatide once daily on gastric emptying in type 2 diabetes--relationship to postprandial glycemia. Regul Pept. 2013; 185:1-8. DOI: 10.1016/j.regpep.2013.04.001. View

20.

Horowitz M, ODonovan D, Jones K, Feinle C, Rayner C, Samsom M . Gastric emptying in diabetes: clinical significance and treatment. Diabet Med. 2002; 19(3):177-94. DOI: 10.1046/j.1464-5491.2002.00658.x. View